NanoValent Pharmaceuticals
About:
NanoValent Pharmaceuticals is a pharmaceutical company.
Website: http://nanovalent.com
Twitter/X: nanovalent_
Top Investors: National Science Foundation
Description:
NanoValent Pharmaceuticals develops novel therapeutic options with enhanced target and delivery characteristics. Their technology will significantly enhance therapeutics. It possesses an experienced core management team with a proven track record of success, supported by a strong clinical and operational capability.
Total Funding Amount:
$510000
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Bozeman, Montana, United States
Founded Date:
2006-01-01
Contact Email:
mlewis(AT)nanovalent.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2013-09-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai